CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853899721
- Phone
- 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-16 | Ullerich Melissa Vera Chief Communications Officer | Grant or award · Employee Stock Option (right to buy) | +16,405 | 16,405 | ||
| 2022-03-16 | Pommer Jerry Lynn Chief Compliance Officer | Grant or award · Employee Stock Option (right to buy) | +15,172 | 15,172 | ||
| 2022-03-16 | Bausch Christoph Lawrence Chief Science Officer | Grant or award · Employee Stock Option (right to buy) | +24,972 | 24,972 | ||
| 2022-03-16 | Erickson Bruce Kipp Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +18,196 | 18,196 | ||
| 2021-11-17 | Beyer Russell P Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2021-11-17 | Reich Samuel J Executive Chairman | Grant or award · Employee Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2021-10-26 | Beyer Russell P Chief Financial Officer | Sale | −278 | $7.90 | $2K | 0 |
| 2021-10-25 | Beyer Russell P Chief Financial Officer | Grant or award | +129 | $7.78 | $1K | 278 |
| 2021-10-22 | Bausch Christoph Lawrence Chief Science Officer | Grant or award · Employee Stock Option (right to buy) | +104,689 | 104,689 | ||
| 2021-10-22 | Bausch Christoph Lawrence Chief Science Officer | Grant or award · Employee Stock Option (right to buy) | +81,425 | 81,425 | ||
| 2021-10-22 | Bausch Christoph Lawrence Chief Science Officer | Grant or award · Earnout Rights (Restricted Stock Units) | +108,086 | 108,086 | ||
| 2021-10-22 | Polvino William James Director | Grant or award · Employee Stock Option (right to buy) | +139,585 | 139,585 | ||
| 2021-10-22 | Polvino William James Director | Grant or award · Earnout Rights (Restricted Stock Units) | +11,748 | 11,748 | ||
| 2021-10-22 | Carillo Carlos N SVP Regulatory Affairs | Grant or award · Employee Stock Option (right to buy) | +17,681 | 17,681 | ||
| 2021-10-22 | Erickson Bruce Kipp Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +232,642 | 232,642 | ||
| 2021-10-22 | Wu Hua SVP Research & Product Dev. | Grant or award · Employee Stock Option (right to buy) | +58,161 | 58,161 | ||
| 2021-10-22 | Wu Hua SVP Research & Product Dev. | Grant or award · Employee Stock Option (right to buy) | +14,540 | 14,540 | ||
| 2021-10-22 | Wu Hua SVP Research & Product Dev. | Grant or award · Employee Stock Option (right to buy) | +6,979 | 6,979 | ||
| 2021-10-22 | Wu Hua SVP Research & Product Dev. | Grant or award · Earnout Rights (Restricted Stock Units) | +32,191 | 32,191 | ||
| 2021-10-22 | Wu Hua SVP Research & Product Dev. | Grant or award · Employee Stock Option (right to buy) | +4,653 | 4,653 |
Page 7 of 9 · 172 trades